ストックスクリーナーアプリを入手
15.34
1.00%
0.1514
前日終値:
$15.19
開ける：
$15.13
24時間の取引高:
109.26K
Relative Volume:
0.15
時価総額：
$467.93M
収益：
$40.61M
当期純損益:
$-29.07M
株価収益率:
-15.22
EPS:
-1.0081
ネットキャッシュフロー:
$-26.70M
1週間 パフォーマンス:
+0.01%
1か月 パフォーマンス:
-0.44%
6か月 パフォーマンス:
+8.42%
1年 パフォーマンス:
+49.82%
1日の値動き範囲:
$14.96
$15.38
1週間の範囲:
$14.96
$16.08
52週間の値動き範囲:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
名前
Clearpoint Neuro Inc
セクター
電話
(949) 900-6833
住所
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
15.34 | 486.85M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
116.00 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.14 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.19 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.44 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.25 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-25 | 再開されました | B. Riley Securities | Buy |
| 2023-10-24 | 開始されました | Stifel | Buy |
| 2023-02-16 | 再開されました | B. Riley Securities | Buy |
| 2022-04-05 | 再開されました | B. Riley Securities | Buy |
| 2021-03-18 | 開始されました | Lake Street | Buy |
| 2020-07-17 | 開始されました | B. Riley FBR | Buy |
すべてを表示
Clearpoint Neuro Inc (CLPT) 最新ニュース
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Conway Capital Management Inc. Makes New $1.66 Million Investment in ClearPoint Neuro, Inc. $CLPT - MarketBeat
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - AOL.com
(CLPT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ClearPoint Neuro (CLPT): MAK Capital group discloses 7.8% ownership in 13G/A - Stock Titan
ClearPoint Neuro (CLPT) Jumps 6.12% to $14.21: Key Levels to WatchSell Signal Alerts - Vinanet
ClearPoint Neuro (NASDAQ:CLPT) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Have Lowered Expectations For ClearPoint Neuro, Inc. (NASDAQ:CLPT) After Its Latest Results - 富途牛牛
Clearpoint Neuro Inc (CLPT) Stock News Today - TradingKey
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
ClearPoint Neuro, Inc. (CLPT) Options Chain - Yahoo! Finance Canada
CLPT Looks 4.6% Overvalued on GF Value™ Ahead of Tuesday Market Drop - GuruFocus
ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case (CLPT) - Seeking Alpha
ClearPoint Neuro Updates Q2 Results and 2026 Outlook - The Globe and Mail
ClearPoint Neuro (CLPT) investors disclose 7.45% beneficial ownership stake - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Cuts Target Price to $25 - Moomoo
Stifel cuts Clearpoint Neuro stock price target on guidance cut - Investing.com
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com South Africa
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks - Benzinga
CLPT Looks 4.7% Overvalued on GF Value™ - GuruFocus
How Does ClearPoint Neuro Inc (CLPT) Perform in Q2? EPS at -$0.3 - GuruFocus
Earnings call transcript: Clearpoint Neuro Q2 2026 misses estimates as shares fall - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
ClearPoint Neuro Q2 Earnings Call Highlights - Yahoo Finance
Clearpoint Neuro Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Issues Quarterly Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat
Transcript : ClearPoint Neuro, Inc., Q2 2026 Earnings Call, Aug 03, 2026 - marketscreener.com
ClearPoint Neuro (CLPT) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
ClearPoint Neuro, Inc. Updates Revenue Guidance for the Year 2026 - marketscreener.com
ClearPoint Neuro Q2 revenue rises 18% but misses estimates - TradingView
ClearPoint Neuro (Nasdaq: CLPT) grows Q2 revenue and updates 2026 outlook - Stock Titan
BRIEF-ClearPoint Neuro Q2 Revenue USD 10.9 Million - tradingview.com
ClearPoint Neuro, Inc. (CLPT) Q2 2026 Earnings - 24/7 Wall St.
ClearPoint Neuro, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
(CLPT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - Moomoo
CLPT Q1 2026 Earnings: EPS Misses Estimates as Stock Gains 2.47%Quarterly Earnings Report - Vinanet
ClearPoint Neuro (CLPT) Gains 2.47% to $14.94 as MedTech Momentum BuildsVolume Nodes - Vinanet
Aspen's Parkinson's Cell Therapy Gets FDA RMAT Designation—Not Approval - Stock Titan
CLPT Q1 2026 Earnings: Wider Loss of -$0.32 per Share Misses Estimates; Stock Gains 3.11%Earnings Decline Risk - Vinanet
Brokers Offer Predictions for CLPT Q2 Earnings - MarketBeat
Clearpoint Neuro Inc (CLPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BlackRock (CLPT holder) discloses 7.1% beneficial stake in ClearPoint Neuro - Stock Titan
CLPT|Clearpoint Neuro Inc|Price:14.412|Chg%:+0.291 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.940|Chg%:+0.360 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:15.310|Chg%:+0.370 - tradingkey.com
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CLPT Q1 2026 Earnings: EPS Misses Estimates as Shares Edge LowerPeak Earnings Alert - Vinanet
TradingKey - TradingKey
Clearpoint Neuro Inc (CLPT) 財務データ
収益
当期純利益
現金流量
EPS
0.76%
大文字化:
|
ボリューム (24 時間):